Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 94

1.
2.

Role of endothelial cell-derived angptl2 in vascular inflammation leading to endothelial dysfunction and atherosclerosis progression.

Horio E, Kadomatsu T, Miyata K, Arai Y, Hosokawa K, Doi Y, Ninomiya T, Horiguchi H, Endo M, Tabata M, Tazume H, Tian Z, Takahashi O, Terada K, Takeya M, Hao H, Hirose N, Minami T, Suda T, Kiyohara Y, Ogawa H, Kaikita K, Oike Y.

Arterioscler Thromb Vasc Biol. 2014 Apr;34(4):790-800. doi: 10.1161/ATVBAHA.113.303116. Epub 2014 Feb 13.

3.

The roles of pathogen-associated molecular patterns in atherosclerosis.

Erridge C.

Trends Cardiovasc Med. 2008 Feb;18(2):52-6. doi: 10.1016/j.tcm.2007.12.003. Review.

PMID:
18308195
4.

Atherosclerosis pathophysiology and the role of novel risk factors: a clinicobiochemical perspective.

Mallika V, Goswami B, Rajappa M.

Angiology. 2007 Oct-Nov;58(5):513-22. Review.

PMID:
18024933
5.

Mineralocorticoid Receptors in the Pathophysiology of Vascular Inflammation and Atherosclerosis.

Moss ME, Jaffe IZ.

Front Endocrinol (Lausanne). 2015 Sep 28;6:153. doi: 10.3389/fendo.2015.00153. eCollection 2015. Review.

6.

Intracranial atherosclerotic stroke: specific focus on the metabolic syndrome and inflammation.

Bang OY.

Curr Atheroscler Rep. 2006 Jul;8(4):330-6. Review.

PMID:
16822400
7.

Emerging role of adipokines as mediators in atherosclerosis.

Zhang H, Cui J, Zhang C.

World J Cardiol. 2010 Nov 26;2(11):370-6. doi: 10.4330/wjc.v2.i11.370.

8.
9.

Obstructive sleep apnea and atherosclerosis.

Lévy P, Pépin JL, Arnaud C, Baguet JP, Dematteis M, Mach F.

Prog Cardiovasc Dis. 2009 Mar-Apr;51(5):400-10. doi: 10.1016/j.pcad.2008.03.001. Review.

PMID:
19249446
10.

[Rheumatoid arthritis, inflammation, and atherosclerosis].

Hürlimann D, Enseleit F, Ruschitzka F.

Herz. 2004 Dec;29(8):760-8. Review. German.

PMID:
15599672
11.

AAV-mediated gene therapy for atherosclerosis.

Lehrke M, Lebherz C.

Curr Atheroscler Rep. 2014 Sep;16(9):434. doi: 10.1007/s11883-014-0434-0. Review.

PMID:
25085755
12.

Cytokines in atherosclerosis: pathogenic and regulatory pathways.

Tedgui A, Mallat Z.

Physiol Rev. 2006 Apr;86(2):515-81. Review.

13.

Translational mini-review series on immunology of vascular disease: inflammation, infections and Toll-like receptors in cardiovascular disease.

Ward JR, Wilson HL, Francis SE, Crossman DC, Sabroe I.

Clin Exp Immunol. 2009 Jun;156(3):386-94. doi: 10.1111/j.1365-2249.2009.03886.x. Epub 2009 Mar 20. Review.

14.

Atherogenesis in rheumatoid arthritis: the "rheumatoid vasculopathy"?

Fietta P, Delsante G.

Acta Biomed. 2009;80(3):177-86. Review.

PMID:
20578409
15.

Reactive oxygen species and thiol redox signaling in the macrophage biology of atherosclerosis.

Tavakoli S, Asmis R.

Antioxid Redox Signal. 2012 Dec 15;17(12):1785-95. doi: 10.1089/ars.2012.4638. Epub 2012 Jun 11. Review.

16.

Psychological stress, vascular inflammation, and atherogenesis: potential roles of circulating cytokines.

Lu XT, Zhao YX, Zhang Y, Jiang F.

J Cardiovasc Pharmacol. 2013 Jul;62(1):6-12. doi: 10.1097/FJC.0b013e3182858fac. Review.

PMID:
23318990
17.

Mechanisms of disease: the evolving role of regulatory T cells in atherosclerosis.

George J.

Nat Clin Pract Cardiovasc Med. 2008 Sep;5(9):531-40. doi: 10.1038/ncpcardio1279. Epub 2008 Jul 8. Review.

PMID:
18607396
18.

Potential therapeutic targeting of platelet-mediated cellular interactions in atherosclerosis and inflammation.

Nagy B Jr, Miszti-Blasius K, Kerenyi A, Clemetson KJ, Kappelmayer J.

Curr Med Chem. 2012;19(4):518-31. Review.

PMID:
22204330
19.
20.

Atherosclerosis as an inflammatory disease.

Tuttolomondo A, Di Raimondo D, Pecoraro R, Arnao V, Pinto A, Licata G.

Curr Pharm Des. 2012;18(28):4266-88. Review.

PMID:
22390643
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk